GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kodiak Sciences Inc (FRA:K27) » Definitions » Net Interest Income (for Banks)

Kodiak Sciences (FRA:K27) Net Interest Income (for Banks)


View and export this data going back to 2020. Start your Free Trial

What is Kodiak Sciences Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Kodiak Sciences (FRA:K27) Business Description

Industry
Traded in Other Exchanges
Address
1200 Page Mill Road, Palo Alto, CA, USA, 94304
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.